ReviewWorld journal of microbiology & biotechnology2025
β-galactanase: an effective tool for the degradation of plant β-ᴅ-galactan.
Review in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Crystal structure of endo-β-1,6-galactanase from Streptomyces avermitilis.Acta crystallographica. Section D, Structural biology · 2026Article
- Galactooligosaccharides Based on β-Galactosidase-Catalyzed Synthesis: Function, Biosynthesis and Optimization Strategy.Foods (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
βGalactanases specifically hydrolyze the interglycosidic bonds of galactose residues in galactan and arabinogalactan, and they are widely distributed in both prokaryotes and eukaryotes. In this review, β-galactanases, including β-1,3-galactanase, β-1,4-galactanase, and β-1,6-galactanase, are summarized from both theoretical and applied perspectives. Studies have demonstrated that β-galactanases primarily belong to the glycoside hydrolase (GH) families 30, 43, and 53. The catalytic mechanisms of the GH30 and GH53 families follow a typical retention hydrolysis mechanism, while only members of the GH43 family adhere to the inverting hydrolysis mechanism. Due to structural differences among β-galactanases, their enzymatic properties and substrate specificities also exhibit significant variations. β-Galactanases have a wide range of applications. For example, β-1,4-galactanases are extensively used in the preparation of galacto-oligosaccharides (GOS) as a food additive and as a fingerprinting tool for medicinal plants. β-1,3-Galactanases and β-1,6-galactanases are less commonly used but are highly effective tools for the analysis of arabinogalactan-II (AG-II) pectin. Furthermore, to expand the application spectrum of β-galactanases, the preparation methods and basic enzymatic properties of these enzymes are summarized. The results demonstrate that β-galactanases have broad application prospects.
Indexed as
Identifiers
40999211What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.